ZARS PHARMA INC.

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

Phase 3

Completed

Conditions: Osteoarthritis

Interventions: Drug: ThermoProfen™ (Matrix Transdermal Ketoprofen/CHADD™ System)
Drug: Placebo Matrix/CHADD Patch
Drug: Ketoprofen matrix/placebo CHADD Patch

First Posted Date: 2007-06-20

Last Posted Date: 2012-05-30

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 679

Registration Number: NCT00488267

Fentanyl Transdermal Patch With CHADD™ for Breakthrough Pain in Patients With Moderate to Severe Non-Malignant Pain

Phase 2

Terminated

Conditions: Pain

Interventions: Drug: Matrix Transdermal Fentanyl/CHADD Drug Delivery System
Drug: Placebo Patch

First Posted Date: 2006-01-18

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 109

Registration Number: NCT00278824

Locations: 🇺🇸
Florida's Institute of Clinical Research, Jacksonville, Florida, United States
🇺🇸
Arizona Reserach Center, Phoenix, Arizona, United States
🇺🇸
Drug Studies America, Marietta, Georgia, United States

and more 12 locations

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Moderate to Severe Cancer Pain

Phase 3

Terminated

Conditions: Pain
Cancer

Interventions: Drug: Fentanyl Transdermal Matrix Patch ZR-02-01

First Posted Date: 2005-08-04

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 24

Registration Number: NCT00126789

Locations: 🇺🇸
Loma Linda Center for Pain Management, Loma Linda, California, United States
🇺🇸
The Center for Clinical Research, Winston-Salem, North Carolina, United States

Fentanyl Transdermal Matrix Patch ZR-02-01 to Treat Chronic, Moderate to Severe Non-Malignant Pain

Phase 3

Terminated

Conditions: Pain

Interventions: Drug: Fentanyl Transdermal Matrix Patch ZR-02-01

First Posted Date: 2005-08-04

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 105

Registration Number: NCT00126763

Locations: 🇺🇸
Drug Studies America, Marietta, Georgia, United States
🇺🇸
Pain Management Institute, Overland Park, Kansas, United States
🇺🇸
Loma Linda Center for Pain Management, Loma Linda, California, United States

and more 3 locations

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Vascular Access Procedures in Children

Phase 3

Completed

Conditions: Pain

Interventions: Drug: Placebo Peel
Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

First Posted Date: 2005-07-29

Last Posted Date: 2012-06-06

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 81

Registration Number: NCT00125255

Locations: 🇺🇸
Children's Hospital, Boston, Massachusetts, United States

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Pulsed Dye Laser (PDL) Therapy in Adults

Phase 3

Completed

Conditions: Pain

Interventions: Drug: S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)
Drug: Placebo Peel

First Posted Date: 2005-05-13

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 80

Registration Number: NCT00110773

Locations: 🇺🇸
Washington Institute of Dermatologic Laser Surgery, Washington, District of Columbia, United States
🇺🇸
Midwest Cutaneous Research, Clinton Township, Michigan, United States
🇺🇸
Laser and Skin Surgery Center of New York, New York, New York, United States

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Skin Filler Injection in the Face

Phase 3

Completed

Conditions: Pain

Interventions: Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)
Drug: Placebo Peel

First Posted Date: 2005-05-13

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 70

Registration Number: NCT00110760

Locations: 🇺🇸
J&S Studies, Inc., Bryan, Texas, United States
🇺🇸
AboutSkin Dermatology, Englewood, Colorado, United States
🇺🇸
Tennessee Clinical Research Center, Nashville, Tennessee, United States

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Non-Ablative Facial Laser Resurfacing in Adults

Phase 3

Completed

Conditions: Pain

Interventions: Drug: S-Caine™ Peel (lidocaine and tetracaine topical cream 7%/7%)
Drug: Placebo Peel

First Posted Date: 2005-05-13

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 54

Registration Number: NCT00110747

Locations: 🇺🇸
Midwest Cutaneous Research, Clinton Township, Michigan, United States
🇺🇸
Laser and Skin Surgery Center of New York, New York, New York, United States
🇺🇸
New York Dermatology, New York, New York, United States

S-Caine™ Peel (Skin Numbing Cream) to Treat Pain During Laser-Assisted Tattoo Removal in Adults

Phase 3

Completed

Conditions: Pain

First Posted Date: 2005-05-13

Last Posted Date: 2005-09-23

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 60

Registration Number: NCT00110734

Locations: 🇺🇸
Laser and Skin Surgery Center of New York, New York, New York, United States

Duration of Skin Numbing Effect Created by the S-Caine™ Peel

Phase 3

Completed

Conditions: Pain

Interventions: Drug: S-Caine™ Peel (lidocaine and tetracaine cream 7%/7%)

First Posted Date: 2005-05-05

Last Posted Date: 2012-06-05

Lead Sponsor: ZARS Pharma Inc.

Target Recruit Count: 40

Registration Number: NCT00110253

Locations: 🇺🇸
Radiant Research, San Diego, California, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy